953-961
REVIEW
Prevalence and prognostic impact of microembolic signals in arterial sources of embolism
A systematic review of the literature
M. A. Ritter, R. Dittrich, N. Thoenissen, E. B. Ringelstein and D. G. Nabavi
962-966
ORIGINAL COMMUNICATION
Hypothyroidism and cerebral vein thrombosis – a possible association
A. R. Peralta and P. Canhão
967-973
ORIGINAL COMMUNICATION
Variations in functioning and disability in multiple sclerosis
A two-year prospective study
C. Ytterberg, S. Johansson, M. Andersson, L. Widén Holmqvist and L. von Koch
974-979
ORIGINAL COMMUNICATION
Is screening for urinary porphobilinogen useful among patients with acute polyneuropathy or encephalopathy?
E. Pischik, V. Kazakov and R. Kauppinen
980-985
ORIGINAL COMMUNICATION
N-terminal pro-brain natriuretic peptide (NT-proBNP) release in children with vagus nerve stimulation
A prospective case series
M. Rauchenzauner, E. Haberlandt, M. Ortler, T. Tatarczyk and M. Laimer, et al.
986-992
ORIGINAL COMMUNICATION
Magnetic resonance imaging findings of leg musculature in Charcot-Marie-Tooth disease type 2 due to dynamin 2 mutation
E. Gallardo, K. G. Claeys, E. Nelis, A. García and A. Canga, et al.
993-1000
ORIGINAL COMMUNICATION
The renin-angiotensin-aldosterone system in cerebral small vessel disease
D. Brenner, J. Labreuche, F. Pico, P. Scheltens and O. Poirier, et al.
1001-1005
ORIGINAL COMMUNICATION
Enhanced corticomotor excitability with dynamic fatiguing exercise of the lower limb in multiple sclerosis
G. W. Thickbroom, P. Sacco, D. L. Faulkner, A. G. Kermode and F. L. Mastaglia
1006-1011
ORIGINAL COMMUNICATION
Identification of internuclear ophthalmoplegia signs in multiple sclerosis patients
Saccade test analysis
M. Jozefowicz-Korczynska, M. Łukomski and A. Pajor
1012-1017
ORIGINAL COMMUNICATION
Acute stroke unit care and early neurological deterioration in ischemic stroke
Jaume Roquer, Ana Rodríguez-Campello, Meritxell Gomis, Jordi Jiménez-Conde and Elisa Cuadrado-Godia, et al.
1018-1022
ORIGINAL COMMUNICATION
A series of patients with subpial hemorrhage: Clinical manifestation, neuroradiological presentation and therapeutic implications
P. Roth, C. Happold, G. Eisele, T. Nägele and M. Weller, et al.
1023-1031
ORIGINAL COMMUNICATION
A multifactorial prognostic index in multiple sclerosis
Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease
J. Mandrioli, P. Sola, R. Bedin, M. Gambini and E. Merelli
1032-1037
ORIGINAL COMMUNICATION
Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson’s disease patients
An ambulatory polysomnographic study
F. Placidi, F. Izzi, A. Romigi, P. Stanzione and M. G. Marciani, et al.
1038-1044
ORIGINAL COMMUNICATION
Clinical features and associated syndromes of mal de debarquement
Y.-H. Cha, J. Brodsky, G. Ishiyama, C. Sabatti and R. W. Baloh
1045-1048
ORIGINAL COMMUNICATION
Valvular heart disease in patients with Parkinson’s disease treated with pergolide. Course following treatment modifications
D. Dupuy, J. P. Lesbre, P. Gérard, M. Andrejak and O. Godefroy
1049-1058
ORIGINAL COMMUNICATION
Open AccessCerebral involvement in axonal Charcot-Marie-Tooth neuropathy caused by mitofusin2 mutations
Knut Brockmann, Steffi Dreha-Kulaczewski, Peter Dechent, Carsten Bönnemann and Gunther Helms, et al.
1059-1066
ORIGINAL COMMUNICATION
Effects of subthalamic nucleus stimulation on striatal dopaminergic transmission in patients with Parkinson’s disease within one-year follow-up
S. Hesse, K. Strecker, D. Winkler, J. Luthardt and C. Scherfler, et al.
1067-1070
ORIGINAL COMMUNICATION
Accelerated forgetting in subjects with memory complaints
A new form of Mild Cognitive Impairment?
F. Manes, C. Serrano, M. L. Calcagno, J. Cardozo and J. Hodges
1071-1078
ORIGINAL COMMUNICATION
Parkinsonian patients show impaired predictive smooth pursuit
J. Ladda, P. Valkovič, T. Eggert and A. Straube
1079-1080
LETTER TO THE EDITORS
Mutations in the
POLG1
gene are not a relevant cause of cerebellar ataxia in Italy
C. Cagnoli, A. Brussino, E. Di Gregorio, P. Caroppo and S. Stola, et al.
1081-1082
LETTER TO THE EDITORS
Association of superficial siderosis of the central nervous system and low pressure headache
D. Holle, I. E. Sandalcioglu, E. R. Gizewski, S. Asgari and D. Timmann, et al.
1083-1084
LETTER TO THE EDITORS
Multiple motor system dysfunction associated with a heterozygous ceruloplasmin gene mutation
A. Jiménez-Huete, J. Bernar, H. Miyajima, Y. Takahashi and J. Álvarez-Linera, et al.
1085-1087
LETTER TO THE EDITORS
Paraneoplastic vasculitic neuropathy related to carcinoid tumor
S. Ashok Muley, K. Brown and G. J. Parry
1088-1089
LETTER TO THE EDITORS
An infected arachnoid cyst in an elderly patient
V. Sivaraman, A. Au-Yeung, S. Brew, A. W. McEvoy and R. Greenwood
1090-1092
LETTER TO THE EDITORS
A novel
KIF5A
/
SPG10
mutation in spastic paraplegia associated with axonal neuropathy
A. Tessa, G. Silvestri, M. F. de Leva, A. Modoni and P. S. Denora, et al.
1093
LETTER TO THE EDITORS
Successful treatment of hyperventilation-induced nystagmus in vestibular schwannoma with oxcarbacepine
G. Ahle, W. Visser, A. Juergens and U. Schlegel
1094-1096
LETTER TO THE EDITORS
Disjunctive saccadesduring smooth pursuit eye movements in ocular myasthenia gravis
T. Sander, A. Sprenger, B. Machner, H. Rambold and C. Helmchen
1097-1099
LETTER TO THE EDITORS
Episodic ataxia:
SLC1A3
and
CACNB4
do not explain the apparent genetic heterogeneity
T. D. Graves and M. G. Hanna
1100-1101
LETTER TO THE EDITORS
Relative frequency of VGKC and ‘classical’ paraneoplastic antibodies in patients with limbic encephalitis
S. Jarius, L. A. Hoffmann, O. Stich, L. Clover and S. Rauer, et al.
1102-1103
LETTER TO THE EDITORS
A case of eosinophilic meningitis in Germany
S. Kirsch, P. Dekumyoy, T. Löscher and R. L. Haberl
1104-1105
PIONEERS IN NEUROLOGY
Wilder Penfield (1891–1976)
D. Todman
1106-1108
JOURNAL CLUB
Neurogenetics: T1 level translational research, myopathies and moyamoya disease
Michael Strupp
1109-1112
COMMUNICATIONS
Communications of the European Neurological Society